Table 1.
Descriptive statistics of included patients
| Patients with ≥ 1 complete ADE reports (N = 2730) | Patients with ≥ 1 serious ADE reportsa (N = 1590) | |
|---|---|---|
| Reports/patient, n (%) | ||
| 1 report | 2379 (87.1) | 1417 (89.1) |
| 2 reports | 285 (10.4) | 148 (9.3) |
| 3 reports | 46 (1.7) | 15 (0.9) |
| 4 reports | 14 (0.5) | Suppressed |
| ≥ 5 reports | 6 (0.2) | Suppressed |
| Mean patient age (SD) | 67.0 (19.5) | 69.1 (18.5) |
| Median patient age [IQR] | 71.0 [55.0, 82.0] | 73.0 [59.0, 83.0] |
| Male sex, n (%) | 1360 (49.8) | 822 (51.7) |
Cell sizes < 5 are suppressed
ADE adverse drug event, IQR interquartile range, SD standard deviation
aSerious ADEs are those with an outcome of fetal defect, permanent disability, hospitalisation, extended hospitalisation, life threatening, or death